The Robert E. Fischell Institute for Biomedical Devices aims to promote new methods of developing and launching new products to deliver improved care to millions, and improve the quality of healthcare in the U.S. - reducing costs, and improving patient access by advancing technology and regulatory science. A key component of the Institute is the Fischell Foundry, which brings together expertise in prototype development and navigating the device commercialization pathway through the U.S. Food and Drug Administration (FDA).